KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 118 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.60 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $173,494 | +104.1% | 44,600 | +137.7% | 0.00% | – |
| Q2 2022 | $85,000 | -24.8% | 18,765 | +22.9% | 0.00% | – |
| Q1 2022 | $113,000 | -7.4% | 15,266 | +31.1% | 0.00% | -100.0% |
| Q1 2021 | $122,000 | -88.9% | 11,646 | -83.7% | 0.00% | -80.0% |
| Q4 2020 | $1,103,000 | +7.0% | 71,273 | +0.9% | 0.01% | +25.0% |
| Q3 2020 | $1,031,000 | +171.3% | 70,634 | +256.7% | 0.00% | +300.0% |
| Q4 2019 | $380,000 | +88.1% | 19,800 | -5.7% | 0.00% | 0.0% |
| Q3 2019 | $202,000 | +17.4% | 21,000 | +14.1% | 0.00% | 0.0% |
| Q4 2018 | $172,000 | – | 18,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |